Global Genome Editing/Genome Engineering Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112230237 | Category: Service & Software | Pages: 100 | Format: PDF | Published Date: April 01,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Genome Editing/Genome Engineering market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genome Editing/Genome Engineering market size is estimated to be worth US$ 3614.8 million in 2021 and is forecast to a readjusted size of USD 6565.6 million by 2028 with a CAGR of 8.9% during review period. Cell Line Engineering accounting for  % of the Genome Editing/Genome Engineering global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While CRISPR segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Genome Editing/Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, and Sangamo Biosciences, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Genome Editing/Genome Engineering market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    CRISPR
    TALEN
    ZFN
Market segment by Application, can be divided into
    Cell Line Engineering
    Animal Genetic Engineering
    Plant Genetic Engineering
Market segment by players, this report covers
    Thermo Fisher Scientific
    Merck
    Horizon Discovery
    Genscript
    Sangamo Biosciences
    Integrated Dna Technologies
    Lonza
    New England Biolabs
    Origene Technologies
    Transposagen Biopharmaceuticals
    Editas Medicine
    Crispr Therapeutics
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genome Editing/Genome Engineering product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genome Editing/Genome Engineering, with revenue, gross margin and global market share of Genome Editing/Genome Engineering from 2019 to 2022.
Chapter 3, the Genome Editing/Genome Engineering competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genome Editing/Genome Engineering market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genome Editing/Genome Engineering research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Genome Editing/Genome Engineering
    1.2 Classification of Genome Editing/Genome Engineering by Type
        1.2.1 Overview: Global Genome Editing/Genome Engineering Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Genome Editing/Genome Engineering Revenue Market Share by Type in 2021
        1.2.3 CRISPR
        1.2.4 TALEN
        1.2.5 ZFN
    1.3 Global Genome Editing/Genome Engineering Market by Application
        1.3.1 Overview: Global Genome Editing/Genome Engineering Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Cell Line Engineering
        1.3.3 Animal Genetic Engineering
        1.3.4 Plant Genetic Engineering
    1.4 Global Genome Editing/Genome Engineering Market Size & Forecast
    1.5 Global Genome Editing/Genome Engineering Market Size and Forecast by Region
        1.5.1 Global Genome Editing/Genome Engineering Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Genome Editing/Genome Engineering Market Size by Region, (2017-2022)
        1.5.3 North America Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
        1.5.4 Europe Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
        1.5.6 South America Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Genome Editing/Genome Engineering Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Genome Editing/Genome Engineering Market Drivers
        1.6.2 Genome Editing/Genome Engineering Market Restraints
        1.6.3 Genome Editing/Genome Engineering Trends Analysis
2 Company Profiles
    2.1 Thermo Fisher Scientific
        2.1.1 Thermo Fisher Scientific Details
        2.1.2 Thermo Fisher Scientific Major Business
        2.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Product and Solutions
        2.1.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Genome Editing/Genome Engineering Product and Solutions
        2.2.4 Merck Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 Horizon Discovery
        2.3.1 Horizon Discovery Details
        2.3.2 Horizon Discovery Major Business
        2.3.3 Horizon Discovery Genome Editing/Genome Engineering Product and Solutions
        2.3.4 Horizon Discovery Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Horizon Discovery Recent Developments and Future Plans
    2.4 Genscript
        2.4.1 Genscript Details
        2.4.2 Genscript Major Business
        2.4.3 Genscript Genome Editing/Genome Engineering Product and Solutions
        2.4.4 Genscript Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Genscript Recent Developments and Future Plans
    2.5 Sangamo Biosciences
        2.5.1 Sangamo Biosciences Details
        2.5.2 Sangamo Biosciences Major Business
        2.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Product and Solutions
        2.5.4 Sangamo Biosciences Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Sangamo Biosciences Recent Developments and Future Plans
    2.6 Integrated Dna Technologies
        2.6.1 Integrated Dna Technologies Details
        2.6.2 Integrated Dna Technologies Major Business
        2.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Product and Solutions
        2.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Integrated Dna Technologies Recent Developments and Future Plans
    2.7 Lonza
        2.7.1 Lonza Details
        2.7.2 Lonza Major Business
        2.7.3 Lonza Genome Editing/Genome Engineering Product and Solutions
        2.7.4 Lonza Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Lonza Recent Developments and Future Plans
    2.8 New England Biolabs
        2.8.1 New England Biolabs Details
        2.8.2 New England Biolabs Major Business
        2.8.3 New England Biolabs Genome Editing/Genome Engineering Product and Solutions
        2.8.4 New England Biolabs Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 New England Biolabs Recent Developments and Future Plans
    2.9 Origene Technologies
        2.9.1 Origene Technologies Details
        2.9.2 Origene Technologies Major Business
        2.9.3 Origene Technologies Genome Editing/Genome Engineering Product and Solutions
        2.9.4 Origene Technologies Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Origene Technologies Recent Developments and Future Plans
    2.10 Transposagen Biopharmaceuticals 
        2.10.1 Transposagen Biopharmaceuticals Details
        2.10.2 Transposagen Biopharmaceuticals Major Business
        2.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product and Solutions
        2.10.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
    2.11 Editas Medicine
        2.11.1 Editas Medicine Details
        2.11.2 Editas Medicine Major Business
        2.11.3 Editas Medicine Genome Editing/Genome Engineering Product and Solutions
        2.11.4 Editas Medicine Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Editas Medicine Recent Developments and Future Plans
    2.12 Crispr Therapeutics
        2.12.1 Crispr Therapeutics Details
        2.12.2 Crispr Therapeutics Major Business
        2.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Product and Solutions
        2.12.4 Crispr Therapeutics Genome Editing/Genome Engineering Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Crispr Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Genome Editing/Genome Engineering Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Genome Editing/Genome Engineering Players Market Share in 2021
        3.2.2 Top 10 Genome Editing/Genome Engineering Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Genome Editing/Genome Engineering Players Head Office, Products and Services Provided
    3.4 Genome Editing/Genome Engineering Mergers & Acquisitions
    3.5 Genome Editing/Genome Engineering New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Genome Editing/Genome Engineering Revenue and Market Share by Type (2017-2022)
    4.2 Global Genome Editing/Genome Engineering Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Genome Editing/Genome Engineering Revenue Market Share by Application (2017-2022)
    5.2 Global Genome Editing/Genome Engineering Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Genome Editing/Genome Engineering Revenue by Type (2017-2028)
    6.2 North America Genome Editing/Genome Engineering Revenue by Application (2017-2028)
    6.3 North America Genome Editing/Genome Engineering Market Size by Country
        6.3.1 North America Genome Editing/Genome Engineering Revenue by Country (2017-2028)
        6.3.2 United States Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        6.3.3 Canada Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        6.3.4 Mexico Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Genome Editing/Genome Engineering Revenue by Type (2017-2028)
    7.2 Europe Genome Editing/Genome Engineering Revenue by Application (2017-2028)
    7.3 Europe Genome Editing/Genome Engineering Market Size by Country
        7.3.1 Europe Genome Editing/Genome Engineering Revenue by Country (2017-2028)
        7.3.2 Germany Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        7.3.3 France Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        7.3.5 Russia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        7.3.6 Italy Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Genome Editing/Genome Engineering Revenue by Type (2017-2028)
    8.2 Asia-Pacific Genome Editing/Genome Engineering Revenue by Application (2017-2028)
    8.3 Asia-Pacific Genome Editing/Genome Engineering Market Size by Region
        8.3.1 Asia-Pacific Genome Editing/Genome Engineering Revenue by Region (2017-2028)
        8.3.2 China Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        8.3.3 Japan Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        8.3.4 South Korea Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        8.3.5 India Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        8.3.7 Australia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Genome Editing/Genome Engineering Revenue by Type (2017-2028)
    9.2 South America Genome Editing/Genome Engineering Revenue by Application (2017-2028)
    9.3 South America Genome Editing/Genome Engineering Market Size by Country
        9.3.1 South America Genome Editing/Genome Engineering Revenue by Country (2017-2028)
        9.3.2 Brazil Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        9.3.3 Argentina Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Genome Editing/Genome Engineering Revenue by Type (2017-2028)
    10.2 Middle East & Africa Genome Editing/Genome Engineering Revenue by Application (2017-2028)
    10.3 Middle East & Africa Genome Editing/Genome Engineering Market Size by Country
        10.3.1 Middle East & Africa Genome Editing/Genome Engineering Revenue by Country (2017-2028)
        10.3.2 Turkey Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
        10.3.4 UAE Genome Editing/Genome Engineering Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Genome Editing/Genome Engineering Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?